Physician

Syed Amir Hamid Ali Shah, M.D.

According to 2025 Medicare claims, Syed Shah, M.D. (NPI: 1447485784) practices hospitalist in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is BAYCARE AURORA, LLC (NPI: 1255387726; TIN: 391947472) and primary practice location at 54311-6519. Shah is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 283 traditional Medicare patients, billed 1,132 HCPCS/CPT codes, and received $107,260 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,382 prescription claims across 279 beneficiaries totaling $51,303 in drug costs, led by Calcitriol (Calcitriol). Open Payments data shows 7 records totaling $230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $27,103 and ending at $107,260. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,288 and ending at $51,303. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	127	313	$27,103
2017	419	1,765	$155,376
2018	405	1,758	$149,754
2019	401	1,546	$147,104
2020	341	1,060	$95,998
2021	171	470	$30,931
2022	240	556	$59,495
2023	250	751	$85,648
2024	283	1,132	$107,260

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	156	$19,288
2016	107	340	$29,208
2017	237	1,289	$301,659
2018	221	1,338	$178,492
2019	210	1,169	$242,044
2020	195	832	$169,700
2021	132	568	$30,686
2022	215	962	$37,241
2023	203	1,104	$54,523
2024	279	1,382	$51,303

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	74	99	$128
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	60	66	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	96	108	$84
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	52	149	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	32	56	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calcitriol	Calcitriol	564	41,482	$9,799
Sps	Sodium Polystyrene Sulfon/Sorb	24	630	$7,095
Sevelamer Carbonate	Sevelamer Carbonate	22	1,200	$5,145
Retacrit	Epoetin Alfa-Epbx	12	206	$1,567
Cinacalcet Hcl	Cinacalcet Hcl	15	782	$853

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$230	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Syed Amir Hamid Ali Shah, M.D.?

Tedicare shows public-source Medicare data for Syed Amir Hamid Ali Shah, M.D. (NPI 1447485784), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Amir Hamid Ali Shah, M.D. have ACO affiliation data?

Syed Amir Hamid Ali Shah, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Syed Amir Hamid Ali Shah, M.D.?

Syed Amir Hamid Ali Shah, M.D. is linked to BAYCARE AURORA, LLC (billing NPI 1255387726) in the available physician profile data.

Does Syed Amir Hamid Ali Shah, M.D. have Open Payments data?

Syed Amir Hamid Ali Shah, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.